ISRCTN ISRCTN72645894
DOI https://doi.org/10.1186/ISRCTN72645894
Protocol serial number 11924
Sponsor North Bristol NHS Trust (UK)
Funder National Institute for Health Research (Grant Codes: PB-PG-1010-23253)
Submission date
17/05/2013
Registration date
17/05/2013
Last edited
26/05/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Sarah Horne
Scientific

Specialist CFS/ME Occupational Therapist
Cossham Hospital
Kingswood
Bristol
BS15 1LF
United Kingdom

Phone +44 (0)117 4145792
Email Sarah.Horne@nbt.nhs.uk

Study information

Primary study designInterventional
Study designRandomised; Interventional; Design type: Prevention, Treatment
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleEarly intervention in fatigue: a feasibility study
Study objectivesThe overall aim of this study is to investigate the feasibility and acceptability of conducting a randomised controlled trial (RCT) to investigate the efffectiveness and cost effectiveness of early intervention for chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) compared with standard medical care in primary care.
Ethics approval(s)Multicentre Research Ethics Committee (MREC), 19/01/2012, ref: 11/SW/0301
Health condition(s) or problem(s) studiedTopic: Primary Care Research Network for England; Subtopic: Not Assigned; Disease: Chronic fatigue syndrome (CFS)/ myalgic encephalomyelitis (ME)
InterventionEarly intervention for fatigue. The intervention is based on the principles of cognitive, behavioural and graded exercise and is delivered by a trained therapist as an individual face to face session with telelphone follow-up sessions. Follow up length: 6 month(s); Study entry: single randomisation only
Intervention typeOther
Primary outcome measure(s)

Recruitment, adherence and follow up. Timepoint(s): 3 and 6 months

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/10/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration100
Total final enrolment44
Key inclusion criteria1. Adult patients (over 18) presenting with an unexplained primary complaint of fatigue, as a new episode, lasting more than one month but less than four
2. Patient has given written informed consent
3. The participant has a Chalder Fatigue score >4 (screened by trial manager); target gender: male and female; lower age limit: 18 no age limit or unit specified
Key exclusion criteriaPatients where fatigue is due to another cause. This means that GPs will not refer patients with an active illness such as cancer, liver cirrhosis etc.
Date of first enrolment05/05/2012
Date of final enrolment31/10/2014

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Frenchay Hospital
Bristol
BS16 1LE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 12/05/2020 26/05/2020 Yes No
Basic results 27/03/2019 27/03/2019 No No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Additional files

ISRCTN72645894_BasicResults_27Mar19.pdf
Uploaded 27/03/2019

Editorial Notes

26/05/2020: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.
27/03/2019: The basic results of this trial have been uploaded as an additional file.
21/01/2019: The contact details for the scientific contact have been updated.
16/01/2017: No publications found, verifying study status with principal investigator.